SNDX

Syndax Pharmaceuticals Inc.

Price

$20.77

return (12m)

34.91%

p/e

-7.76

p/bv

113.46

DIVIDEND YIELD

0.00%

SNDX price

Syndax Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SNDX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.65%

3 months

5.06%

1 year

34.91%

2 years

1.32%

5 years

31.87%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals SNDX

Valuation

P/E

-7.76

Sector -4.38

Industry -4.38

P/BV

113.46

Sector 2.02

Industry 2.02

P/Revenue (PSR)

6.79

Sector -4.40

Industry -4.40

EV/EBITDA

-47.63

Sector -263.09

Industry -263.09

EV/EBIT

-47.62

Sector -702.90

Industry -702.90

P/EBITDA

-9.61

Sector -4.39

Industry -4.39

P/EBIT

-9.61

Sector -4.73

Industry -4.73

P/Total Assets

2.43

Sector 1.49

Industry 1.49

P/Net Current Assets

-126.81

Sector -11.70

Industry -11.70

P/Working Capital

2.98

Sector -3.19

Industry -3.19

EPS

-2.48

Sector -2.14

Industry -2.14

BVPS

0.17

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

95.78%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-50.39%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-50.41%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-76.98%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-87.52%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.10

Sector 0.03

Industry 0.03

Profitability

ROE

-1,461.99%

Sector -65.14%

Industry -65.14%

ROA

-31.37%

Sector -65.53%

Industry -65.53%

ROIC

-270.68%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.77

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-0.92

Sector -6.07

Industry -6.07

Net Debt / EBIT

-0.92

Sector -8.26

Industry -8.26

Net Debt / Equity

2.24

Sector -1.07

Industry -1.07

Gross Debt / Equity

38.95

Sector -0.05

Industry -0.05

Equity/Assets

0.02

Sector 0.41

Industry 0.41

Liabilities/Assets

0.98

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

12.54%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals SNDX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SNDX Syndax Pharmaceuticals Inc.	$20.77	30.88%	0.00%	-7.76	113.46	-1,461.99%	-87.52%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SNDX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Syndax Pharmaceuticals

Syndax Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

21 years

Founded: 2005

2016

Time since IPO - 10 years

43

Employees

Syndax Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.71 billion, with shareholders equity totaling $15.10 million.

The company employs approximately 43 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Syndax Pharmaceuticals Inc. reported $252.25 million in revenue, generating net income of $-220.76 million.

Key financial metrics include a P/E ratio of -7.76, a price-to-book (P/B) ratio of 113.46, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SNDX.

Market cap

$1.71 billion

Net worth

$15.10 million

$15,100,000.00

Assets

$703.65 million

$703,650,000.00

Total Shares Outstanding

89.00 million

89,000,000

Average Daily Trading Volume

$1.96 million

$1,959,199.38

Sector

Health Care

Industry

Biotechnology

SNDX

SNDX revenue and profits

Financial Results SNDX

DRAG THE FRAME TO SEE MORE DATA

SNDX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Syndax Pharmaceuticals (SNDX) today?

A cotação de Syndax Pharmaceuticals (SNDX) hoje está em US$ 20.77, com uma variação de 34.91% em relação ao último ano. A cotação de Syndax Pharmaceuticals (SNDX) iniciou o ano negociando na casa dos US$ 21.01 e hoje está em US$ 20.77. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Syndax Pharmaceuticals (SNDX) e dados de ações do Ibovespa e mercados internacionais.

Quando Syndax Pharmaceuticals (SNDX) paga dividendos?

Syndax Pharmaceuticals (SNDX) não distribuiu dividendos no último ano.

Is Syndax Pharmaceuticals (SNDX) a good investment?

Atualmente, Syndax Pharmaceuticals (SNDX) está cotada a US$ 20.77, com um P/L de -7.76, representando um desvio de 1,439% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 34.91 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 34.91%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Syndax Pharmaceuticals (SNDX) stock?

Investir em ações de Syndax Pharmaceuticals (SNDX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Syndax Pharmaceuticals (SNDX) yield today?

A rentabilidade de Syndax Pharmaceuticals (SNDX) foi de -7.65% no último mês, 34.91% no último ano e 31.87% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Syndax Pharmaceuticals (SNDX) hoje, o investimento total seria de US$ 2,077.00, com base na cotação atual de US$ 20.77.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,802.08
Em 5 anos: US$ 2,738.94
Em 10 anos: US$ 2,077.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SNDX

Syndax Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SNDX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SNDX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Syndax Pharmaceuticals

Syndax Pharmaceuticals Inc.

United States

21 years

2016

43

PROFIT X PRICE SNDX

Financial Results SNDX

SNDX cash flow

Asset, Revenue and Profit Growth - SNDX

SNDX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions